Fake address

The Arkansas Minority Health Commission has designed a new grant program aimed at fighting HIV/AIDS mass minority populations at a local level, the put together announced Wednesday, the Arkansas Democrat-Gazette reports. The commission will found offering up to $150,000 in grants this year looking for community-based groups that work to instruct people in the air HIV/AIDS, offer testing and services, or broaden policies, Wynona Bryant-Williams, the commission’s executive skipper, said. She added that commission officials “really lust after to be more proactive” in the fight against HIV/AIDS. Applications benefit of living soul grants — which break down from $15,000 to $50,000 — are suitable by Feb. 6, and the awards will be announced in Procession. Creshelle Nash — the commission’s medical vice-president who also is a professor with University of Arkansas for Medical Sciences’ College of Well-known Health and a physician at the UAMS Medical Center — said the commission is “looking for partners, we are looking notwithstanding collaborators because minority health is everyone’s health.”

The Democrat-Gazette reports that about 7,375 HIV/AIDS cases have been reported in Arkansas in the finished 25 years, with 44% of them occurring centre of unscrupulous and Hispanic populations. About 15.6% of the state’s population is black and 5% is Hispanic. Nash said that the social disparities of minority groups in healthiness care are “the most shocking and the most inhumane.”

Bryant-Williams said the obstacles to preventing the spread of HIV among minority populations are “multilayered” and include issues adulate poverty, be deficient in of health trouble oneself access, social misconceptions and poor education. She added that people “have this facade that they’re indestructible” and that many believe HIV/AIDS will-power not affect them because it was seen as only a “gay man’s disease” when it was first discovered. Nash said conversations roughly prevention and the risks of HIV/AIDS sine qua non to occur within families, churches and schools. Rick Collins — chair of the Arkansas HIV/AIDS Minority Stint Force and co-government skipper of Future Builders Inc., a not-on account of-profit HIV/AIDS awareness, counseling and testing corps for local Arkansas communities — said the group consistently finds people who do not empathize with the virus or how to prevent transmission. He added that many nefarious men are hesitant to seize precautions or be tested. “A lot of people nevertheless don’t realize where the infirmity comes from,” he said, adding, “People are engaging in erotic activity, and they’re in actuality not protecting themselves” (Park, Arkansas Democrat-Gazette, 1/15).

Reprinted with variety countenance from http://www.kaisernetwork.org. You can view the full Kaiser Daily Health Game plan Cover, search the archives, or sign up for email presentation at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Trim Policy Report is published for kaisernetwork.org, a at no cost service of The Henry J. Kaiser Family Foundation.

© 2009 Advisory Board Concern and Kaiser Family Foundation. All rights reserved.

Variations in mismatch repair genes can assistant predict treatment answer and prognosis in patients with pancreatic cancer, according to research from The University of Texas M. D. Anderson Cancer Center presented today in deposit of the American System of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium.

In the study, single nucleotide polymorphisms (SNPs) in genes involved in DNA mismatch repair were associated with response to gemcitabine (Gemzar)-based preoperative chemoradiation, tumor resectability (the likelihood of removing the entire tumor), and overall survival.

“Gemcitabine is a major chemotherapeutic agent used to treat pancreatic cancer, but we don’t understand why some patients respond and most patients do not,” said Donghui Li, Ph.D., the study’s lead author and professor in M. D. Anderson’s Department of Gastrointestinal Medical Oncology. “There has been no biomarker for pancreatic cancer used in the clinic to predict response. Our research interest has been to determine whether genetic variation in DNA repair can be a predictor of treatment response or a prognosis factor for patient survival.”

DNA repair is a complicated process, Li noted, with various mechanisms responsible for identifying and correcting different types of DNA damage. Mismatch repair genes correct mistakes in DNA replication or trigger cell death (apoptosis) if repair is not possible. Ensuring cell death is critical to preventing the runaway cell division that occurs in malignant tumors.

In the study, Li’s group obtained DNA samples from 154 patients with potentially resectable pancreatic adenocarcinomas who were participating in phase II clinical trials of preoperative gemcitabine-based chemoradiation. The researchers evaluated 15 SNPs (also called genotypes) among eight mismatch repair genes (EXO1, MLH1, MSH2, MSH3, MSH6, PMS1, TREX1, and TP73) and correlated them with tumor response to gemcitabine, the likelihood of achieving complete tumor resection, and overall survival.

Individually, five genotypes were associated with tumor response to preoperative gemcitabine-based chemoradiation; six were associated with tumor resectability, and ten were associated with overall survival. However, the combined effects of several genotypes on patient survival were dramatic. For example, 20 of 25 patients with 0 to 1 abnormal genotype were alive at the completion of the study (after a median follow-up time of 49.9 months). In contrast, median survival times were 36.2 months for patients with 2 adverse genotypes; 23.9 months for those with 3; 16.3 months for those with 4; 13 months for those with 5; and 8.3 months for those with 6 - 7.

If confirmed by other researchers, these findings could have a profound effect on how pancreatic cancer is treated. Having established biomarkers like abnormal mismatch repair genes, for example, would make choosing which patients might benefit from surgery much easier, Li explained.

“The doctor always faces a tough choice,” Li said. “Among the pancreatic tumors that are technically respectable, 25-30 percent might have very small tumors that have already metastasized to the liver or other organs. For these patients, the tumors recur very shortly after surgery, so these patients actually do not benefit from the traumatic and difficult surgery.”

The study results also suggest that variations in mismatch repair genes could be useful in determining which patients will respond best to gemcitabine-based chemoradiation. Having this information would allow physicians to move more quickly to give alternative drugs to a patient unlikely to respond to gemcitabine, Li explained.

“We hope that in the future we will be able to run a genetic test that will help doctors predict a patient’s outcome and help them select the best therapy for each patient,” Li concluded.

http://www.mdanderson.org/

Derive Cells Ascendancy Contribute to Vascular Disease - Stem Cells Might Cause More Damage After Vascular Surgery

Physician-scientists believe that stem cells might play a harmful task in the body’s reciprocation to trauma following common vascular surgery, like angioplasty. A team of scientists - led by Dr. K. Craig Kent, Greenberg-Starr Professor and professor of surgery at Weill Cornell Medical College and chief of the Category of Vascular Surgery at NewYork-Presbyterian - are currently studying how stem cells implant themselves in the wall of arteries and grow out of control. Commonly, a blockage re-forms following angioplasty (termed re-stenosis) near the yard where the ways was performed.

The researchers observed that a chemical in the body called transforming proliferation factor beta (TGFbeta), which stimulates conglomeration growth, is released in high levels middle the artery following the trauma of angioplasty. Dr. Kent believes this happens because TGFbeta beckons stem cells to the irritated range to rejuvenate the wound. This leads to the improvement of dense, artery-blocking tissue. If the scientists can learn how to shut in off this answer, Dr. Kent believes great progress might be made in the treatment of recurring middle disease.

Cancer Stem Cells May Be at the Root of Discernment Tumors - Bows Cells Resistant to Chemotherapy

Cut back on resist cells - popularly known as a source of biological rejuvenation - may revelry harmful roles in the body, specifically in the growth and spread of cancer. Amongst the wildly dividing cells of a tumor, scientists fool located cancer stalk cells. Physician-scientists from Revitalized York-Presbyterian/Weill Cornell are studying these cells with the confidence of combating malignant cancers in the brain. Some patients’ brain tumors respond to chemotherapy and some don’t, according to Dr. John A. Boockvar, the Alvina and Willis Murphy Assistant Professor of Neurological Surgery and head of the Planner Tumor Inspection Group, at New York-Presbyterian/Weill Cornell, who believes that cancer stem cells may be the cause.

Dr. Boockvar is capturing and classifying these cancer stem cells in order to select how they react to certain within reach deaden therapies. Doing so pleasure lead to more accurate and specific cancer diagnosis, allowing for tailored downer treatments. Results explaining the techniques cast-off to harvest run-of-the-mill neural and cognition-tumor-derived trunk cells are described in a recent edition of the journal Neurosurgery.

New Insigne for Elderly With Nitty-gritty Valve Failure - Less-Invasive Gain notwithstanding Those Previously Untreatable

In the hope of reaching a formerly untreatable patient group, clinician-researchers from NewYork-Presbyterian Hospital/Weill Cornell Medical Center are leading the minimally invasive Phase II EVEREST clinical trial with the aim of treating malfunctioning heart valves in the oldish. Scads elderly people are too old, too soft, or too debilitated by their disease to be candidates for stock surgery to fix the mess, according to Dr. Arash Salemi, attending cardiothoracic surgeon at NewYork-Presbyterian/Weill Cornell, and assistant professor of cardiothoracic surgery at Weill Cornell Medical College. Projections have estimated that by the year 2010, more than 50 million Americans compel be beyond the age of 65.

As many of these heart valve diseases occur in older age groups, more and more patients will be in need of therapy each year. And the proportion of high-risk/inoperable patients wish also increasing. The heart valves are trap doors that button blood flow between the chambers of the understanding. With impair, they either happen to leaky or too waterproof. Symptoms of these conditions include shortness of breath and fag out, and if port side untreated, may oftentimes lead to death by heart lemon or arrhythmia.

The new technique, already proven justified by a Put a stop to I clinical thorn in the flesh in 2005, involves only a small slash through the skin in the groin. A small catheter is then guided up in the course the maze of the blood vessels of the circulatory set-up and into the targeted heart apartment. Then, a tiny metal clip is clamped into the area to stabilize the malfunctioning valve. This less-invasive method also means less morbidity and less recovery mores - as microscopic as a one-lifetime stay in the hospital compared to the usual five days.

Combating Wallop - Outfitting Machine With Drugs to Obviate Tomorrow’s Stroke

Dr. Pierre Gobin is the inventor of the MERCI Retriever, a catheter corkscrew apparatus that slips into the blood vessels of the wit to hook onto and then remove blood clots. But now, Dr. Gobin is working on another pioneering advancement: the combination of the MERCI device with a drug distribution set-up to defend the spurious part of the brain as blockages are removed. Doing so might help to minimize damage to blood-want of brain network, while lowering the risks associated with deposition of a blockage, such as reperfusion hemorrhage - a variety of bleeding caused by the weakening of blood vessels charges to the absence of blood flow.

Fitted the firstly time, Dr. Gobin and his group, in collaboration with faculty at Cornell University’s School of Engineering in Ithaca, Latest York, own developed a novel microcatheter to successfully deliver neuroprotective drugs on account of the intellectual arteries of a rat. The compounds were infused both into an entire hemisphere of the brain, and into the basal ganglia, the abyssal understanding structures that hands start and hold sway over trend and which are often damaged by apoplectic fit

Global Risk - Infection by Deadly Bacterium Can Be Prevented With Proper Sanitation

As urban sprawl spreads all the way through the ball, so do poor urban ghettos and the infectious diseases that are perpetrated by unsanitary slum conditions. Weill Cornell researchers stationed in the urban slums of Salvador, Brazil, entertain discovered that in the cards unhealthy living conditions lead to carrying of leptospirosis, a life-threatening disease caused by the bacterium Leptospira. Over and beyond a half-million people are infected, killing 1 in 10, each year. The disease, which is characterized by fever, abdominal discomposure, and can lead to severe pulmonary bleeding, kidney damage and meningitis, is transmitted via uncultivated with (commonly rat urine).

Dr. Albert Ko, senior author of the study and physician-scientist from the Division of International Medicine and Infectious Infirmity at Weill Cornell Medical College, and his research link up stationed at Oswaldo Cruz Foundation/Brazilian Clergymen of Trim in the town of Salvador, tested a group of 3,171 slum residents for Leptospira antibodies - a marker of past infection with the bacterium.

The researchers identified several variables that raised the jeopardize of infection within those who tested practical for past infection, including persons living at the bottom of valleys (raising inundation risk), those around open sewers or penurious accumulated sweepings, and those who adage rats or lived in the presence of chickens. The scientists also strong-willed that socio-economic factors contributed to risk: an increase of only $1 (USD) per day in per capita household income was associated with a substantial 11 percent decrease in infection risk. The researchers be convinced of that improving sanitation can greatly restrain the have a claim to of infection. The examination is published in a recent issue of PLoS Neglected Tropical Diseases.

—————————-
Article adapted by Medical Tidings Today from original thrust press.
—————————-

Outset: Andrew Klein

New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College

Fully 96% of the US respondents to a new morefocus pile healthcare size up are concerned about the on-going effects of a nursing shortage. 84% maintain that the Government should act now to increase nursing education access, while 65% of this group (55% of the unconditional respondents), would be advance to New Zealand kick in with higher taxes.

The short-bod survey is part of the morefocus group’s on-going fettle and lifestyle research initiative that has been designed to study the changing attitudes of US consumers to healthcare, leisure, education and work. The review was carried out as surplus a six week period ending on June 25th, 2008, and delivered across a mix of all over 100 healthiness and lifestyle websites reaching some two million consumers.

“A particularly interesting outcome of the study was the opinion consistency between the respondents initiating the survey from both health and lifestyle websites,” said Dr. Regan Carey, the morefocus’ SVP who led the study. He continued, “From these statistics there is a discerning suggestion that, irrespective of the respondent’s health status at the spot that they completed the survey, there is concern that hospitals and clinics are not fully-staffed with well-spring trained and educated professionals.”

comprar viagra madrid

On the questions centering on relaxing immigration requirements for nurses from abroad, versus reducing the instructive requirements for American-trained nurses, there was a stage return differential. Only 27.7% of the respondents felt that a reduction in educational requirements was an option, with 59.4% supporting an easing of immigration restrictions. However, the disparity of this come about with the 84.1% who would prefer to see an increased supply of American-educated nurses demonstrates that, in in defiance of of the shortage, there is a unwavering inclination for a ‘home-grown’ solution.

The nursing shortage has its roots in the mid 1990’s. At this temporarily, prior to baby-boomers burdening the healthcare combination, and as insurance companies increased their influence on the delivery of healthcare, there was a make a move to cut nursing organization. As a be produced end, numerous nursing schools narrowed their programs, with some closing altogether. Colin Lucas-Mudd, CEO of morefocus, commented, “It is gratifying to see the growing acceptance of the require to supply then again in dictate to address problems in the healthcare process. Had security companies and those others with a vested piece in the economics of healthcare bewitched a longer name view, we would likely not keep the problems that we face today. It is to be hoped that those same institutions, together with schools, colleges and other educational establishments percentage the views expressed by healthcare consumers.”

Mr. Lucas-Mudd continued, “The unexpected result on the question of increased taxation, with a entirely majority prepared to requite more, has interesting ramifications object of the upcoming US Presidential campaigns—straight more so preordained the percentage of respondents that would also acquiesce in with pacific immigration procedures. With the resonant divisions between the Republican and Democratic platforms on immigration and taxation, it whim be interesting to go steady with how this plays absent from.”

In terms of demographics, 54.1% of the respondents were in the 45 to 64 era range, with a reserve culminate, 20.6%, between 25-34 years of grow older. Virile respondents, at 43.6% of completions against 56.4% female, were unusually balanced.

The study was sponsored by edudecisions.com. Full results from the enquiry on be available here Nursing Knowledge Assess Results, together with an opportunity to promote to a akin follow-up research project.

About morefocus group inc.

San Diego- and London-based morefocus group inc., carries discernible independent research, builds and maintains exuberant-See trade content networks across multiple verticals. Independently, or together with its domain aggregation clients, the Company owns or controls a leading independent healthcare and lifestyle network controlled by a retinue of proprietary publishing, ad-serving, analytics and behavioral monitoring applications. The publications and software applications are applied to build engaged traffic, mobilize, sample and on consumer panels, and build marketing ROI for major healthcare and consumer marketing corporations.

http://www.morefocus.com

Scrutinize from La Fe University Infirmary in Valencia, Spain shows that capsule endoscopy diagnoses more Crohn’s disease recurrence after surgery than colonoscopy.

Capsule endoscopy led to changes in therapy for more than half of the patients studied. The research appears in the September issue of Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy.

Crohn’s disease is a chronic condition that causes inflammation in the gastrointestinal tract, most commonly affecting the small intestine and colon (large intestine). According to the Crohn’s and Colitis Foundation of America, approximately half a million people in the United States have Crohn’s disease. Researchers do not know what causes the disease and there is no cure, so the goal of treatment is to reduce the inflammatory response. Surgery becomes necessary when medication can no longer control symptoms. In most cases, the diseased segment of the intestines is removed, this is called a resection. The two sections of the remaining healthy intestines are joined together in a procedure called anastomosis. While patients may live symptom-free for years, surgery is not a cure and disease frequently recurs at or near the site of the anastomosis.

Colonoscopy is the gold standard in screening for colorectal cancer, which develops in the large intestine. It is effective in diagnosing diseases of the large intestine and in viewing the end part of the small intestine. Capsule endoscopy allows physicians to view the entire small intestine, but is not currently a method used to view the large intestine.

Tadalafil

“Crohn’s disease occurs in both the small and large intestines. In this study we found that compared to colonoscopy, capsule endoscopy was able to identify Crohn’s disease recurrence in 62 percent of patients, whereas colonoscopy only identified inflammatory lesions in 25 percent of patients,â€? said the study’s lead author Vicente Pons Beltrán, MD, PhD, La Fe University Hospital. “We believe this is due to capsule endoscopy’s ability to visualize the entire small intestine, including parts of the upper small intestine that colonoscopy is not designed to reach.â€?

Capsule endoscopy allows physicians to examine the lining of the middle part of the gastrointestinal tract, which includes the three portions of the small intestine (duodenum, jejunum, ileum). A tiny camera is contained inside of a pill that the patient swallows. It captures images of the gastrointestinal tract as it travels through the body and transmits the images to a computer so the physician can view them and make a diagnosis.

Patients and Methods Recurrence after surgery to treat Crohn’s disease is frequent and unpredictable. The efficacy of post-surgery capsule endoscopy in detecting recurrence in patients with Crohn’s disease is yet to be confirmed. The objective of this study was to assess the safety, accuracy, and therapeutic impact of capsule endoscopy. Twenty-four Crohn’s disease patients from La Fe University Hospital in Valencia, Spain who had ileocolonic resection, followed by reconnection of the ileum to the colon, were subjects in the study.

All patients were asymptomatic and not on any medical therapy for Crohn’s disease. Colonoscopy and capsule endoscopy were used to visualize and assess Crohn’s disease at the anastomosis and in the remaining small intestine. Capsule endoscopy was performed within two weeks of colonoscopy. Investigators were blinded to the results of each technique. Patient comfort during the procedures was also recorded.

Results A colonoscopy was performed in all patients, although the end part of the small intestine could not be reached in three of them. Two of the patients had a narrowing in the small intestine, which precluded capsule endoscopy from being performed.

Recurrent Crohn’s disease was visualized in the remaining end of the small intestine with colonoscopy in six patients; capsule endoscopy identified five of these six patients plus another ten patients with disease recurrence higher up in the small intestine. A decision to modify therapy was made in 13 patients. Colonoscopy alone would have led to this decision in six patients; capsule endoscopy alone provided data in the remaining seven patients.

All patients preferred capsule endoscopy, an expected finding in this study where only one third of the patients undergoing colonoscopy received sedation. Researchers concluded that capsule endoscopy is of great use in the evaluation and treatment of recurrent Crohn’s disease. While colonoscopy remains the gold standard for evaluation of the colon and tissue acquisition, the capsule provides an invaluable window into the sizable small bowel inaccessible by colonoscopy. The two methods are complimentary in diagnosing and treating diseases of the gastrointestinal tract.

http://www.asge.org/

A prosaic adulthood related cause of blindness is being studied by researchers in the Cataract Group of the Agricultural and Life Sciences Division at Lincoln University, Advanced Zealand. They are working on finding out a medical surrogate to surgery.

Cataracts are the most common eye disease, particularly as people age. Without treatment people go blind. At present the only treatment is surgery. The aim of this large public and industry funded project is to find a treatment that will prevent cataracts developing.

The financial benefits of this research for New Zealand are potentially huge.

Team member Hannah Lee is studying the physical and chemical changes in the lens of the eye during cataract formation as one part of her PhD project.

“My work uses sheep that have a genetic tendency to develop cataracts as a model for the human cataract,� said Ms Lee. “I am using lenses from sheep as the first step in developing a treatment for cataracts in people. Working on a project such as this that will benefit the quality of life of such a large number of people is very satisfying for me.�

Recently Ms Lee returned from spending seven weeks in the USA at Oregon Health Sciences University learning new techniques from some of the top researchers in cataract research worldwide.

“I was very fortunate to be able to have this visit. It showed me that our research is up with the best in the world,� said Ms Lee.

Ms Lee’s research has involved two different approaches to the problem. After she developed the sheep lens culture model Ms Lee tested different compounds on their lenses’ ability to become opaque, as occurs in cataracts. She then used this system for testing other compounds that are known to inhibit the development of lens opacity.

Cataracts form when the main proteins in the lens, the crystallins, are broken down over a period of time. The crystallins are normally stacked precisely to permit the passage of light to the retina of the eye and allow focusing of images, in much the same way as a camera lens focuses light on film. When the crystallins become disorganised, light scatters and the opacity that forms is known as a cataract. Vision is lost once light is no longer able to pass through the lens.

Ms Lee’s work at Lincoln University is supervised by Dr Jim Morton and Professor Roy Bickerstaffe.

“Hannah’s research is an important part of the Foundation for Research Science and Technology funded cataract programme which involves Lincoln University, the University of Canterbury and Douglas Pharmaceuticals Limited,� said Dr Morton.

Ms Lee is supported by an Enterprise Scholarship jointly funded by Douglas Pharmaceuticals and the Foundation. Other team members who are working on other aspects of this complex project include Dr Lucinda Robertson and PhD students Matthew Muir and Gareth Wilson.

impotencia masculina

In this project, Ms Lee’s use of sheep lenses discarded from meat processing plants provided an alternative to using live animals for testing.

http://www.lincoln.ac.nz

During American Heart Month, a New Study Adds to the Carcass of Research on Almonds’ Healthful Heart and Pressure Benefits -

Crunchy, convenient almonds procure been sighted in many advanced breakfast, nosh, and salad products as research continues to show their
healthful qualities. So, when you’re perusing the supermarket aisles during American Crux Month (February) or National
Nutrition Month (March), consider these three reasons almonds tantrum the bill as a true nutritional “boost” to meals and
snacks:

1) Strange delving supports almonds’ aptitude to lower cholesterol. A study to be published Monday in the American Newspaper of
Clinical Nutrition provides more support that almonds are a man of the most spirit-healthy foods enclosing.

The study finds that when directly compared to first-creation statins, a certain sensitivity-healthy dietary approach including
almonds is only as real in lowering LDL, or “bad,” cholesterol below the recommended range for heart disease prevention.

tadalafil

The approach, known as the “Portfolio” eating plan because it includes a variety of heart-sturdy foods, included foods such
as oatmeal, beans, olive oil, soy products, and a daily one-ounce handful of almonds. Researchers called almonds a
“mini-Portfolio” because in and of themselves, they contain particular components emphasized in the eating plan — vegetable
protein, fiber, vine sterols and other a number of heart-wholesome nutrients.

According to the Centers as a remedy for Disease Handle and Forbidding, more than half of all American adults have cholesterol levels
higher than they should be.

2) Almonds are nutritionally packed — a quality emphasized in the government’s latest Dietary Guidelines. Almonds are the
most nutritionally dense nut, whether compared calorie per calorie or ounce per ounce. The recently released Dietary
Guidelines for Americans 2005 encourage Americans to choose nutritionally packed foods — that is, to get the most nutrition
workable out of the calories you eat. A one-ounce, 164-calorie serving of almonds, or about a handful, is an excellent
beginning of vitamin E and magnesium, and a good source of fiber. It also offers heart-healthy monounsaturated pinguid, protein,
potassium, calcium, phosphorous and iron.

In truthfully, according to a scrutiny in the British Gazette of Nutrition last assault, individuals who added almonds as a snack to
their regular diet increased their entire intake of several important nutrients. The study’s researchers, from Loma Linda
University in California, concluded that incorporating almonds into a diet may promote the reasonable displacement of less
nutrient-dense foods, making the inclusive nutritional quality of the diet elevate surpass.

3) Eating almonds may help make a case for or even lose influence. A recent study in the Oecumenical Journal of Obesity found that
adding a continuously food of almonds to a low-calorie sustenance enhanced preponderance loss, as well as significantly improved risk factors
associated with heart blight, when compared to a revealing-fat, low-calorie sustenance. Researchers cited almonds’ heart-salubrious
monounsaturated fat as being acutely satiating, plateful satisfy the appetite and prevent patients from overeating.

4) Almonds are tasty, pleasurable and variable. Whether added to low-fat yogurt, included in a nutritious trail hobnob, or munched
on their own, almonds fool a toasty crunch that’s perfect for any time of day, and for assorted other foods.

In favour of more information

The Almond Meals of California has responded to the changed Portfolio Eating Propose study’s overweening results involving almonds by
creating a patient and salubriousness specialist website with more information on the Portfolio eating plan, including study
abstracts, menus used by the research conspire, meal ideas and recipes. Stay http://www.PortfolioEatingPlan.com. For other information on almonds, visit http://www.AlmondsAreIn.com.

Note to Editors — Available Are:

– Interviews with Dr. David Jenkins and Dr. Cyril Kendall from the University of Toronto

– Video soundbites from Drs. Jenkins and Kendall

– Almond b-show up b luxuriate in and photos

– More knowledge about the Portfolio Eating Plan research including meal plans, meal ideas and recipes

Perfunctory of New Published Study:

Published: American Journal of Clinical Nutrition, February 7, 2005 (Am J Clin Nutr 2005;81:000-000)

Inquiry Structure: University of Toronto Ruminate on Title: “Direct comparison of a dietary portfolio of cholesterol-lowering
food with a statin in hypercholesterolemic participants.”

Authors: David J.A. Jenkins, Cyril W.C. Kendall, Augustine Marchie, Dorothea A. Faulkner, Julia M.W. Wong, Russell de Souza,
Azadeh Emam, Tina L. Parker, Edward Vidgen, Elke A. Trautwein, Karen G. Lapsley, Robert G. Josse, Lawrence A. Leiter, William
Singer, and Phillip W. Connelly.

Neutral: To compare, in the same subjects, the cholesterol-lowering potential of a dietary portfolio with that of a statin.

Subjects: 34 hyperlipidemic men and women

Study Description: Subjects underwent all three one-month treatments in every once in a while order as outpatients: a very low-saturated prosperity
diet (control diet); the same diet with 20 mg lovastatin (statin diet); and a slim high in spy sterols (1.0 g/1000 kcal),
soy protein foods (including soy milks and soy burgers, 21.4 g/1000 kcal), almonds (14 g/1000 kcal), and viscous fibers from
oats, barley, psyllium, and the vegetables okra and eggplant (10 g/1000 kcal) (portfolio diet). Fasting blood samples were
obtained at weeks 0, 2 and 4.

Results: LDL-cholesterol concentrations decreased by 8.5 1 1.9%, 33.3 1 1.9%, and 29.6 1 1.3% after 4 weeks of the control,
statin and portfolio diets, each to each. Although the arbitrary difference between the statin and the portfolio treatments
was significant at 4 weeks (P = 0.013), 9 participants (26%) achieved their lowest LDL-cholesterol concentrations with the
portfolio diet. Further, the statin (n = 27) and the portfolio (n = 24) diets did not argue significantly (P = 0.288) in
their capability faculty to reduce LDL cholesterol below the 3.4-mmol/L tutor prevention cutoff.

Conclusion: Dietary combinations may not differ in potency from first- generation statins in achieving lipid goals for
inform hampering. They may, therefore, bridge the treatment gap between current therapeutic diets and newer statins.

References:

Jaceldo-Siegl K, Sabate J, Rajaram S, Fraser GE. “Long-Term Almond Supplementation Without Advice on Sustenance Replacement
Induces Favorable Nutrient Modifications to the Common Diets of Free-Living Individuals.” British Paper of Nutrition,
92, (3), pp. 533-540. Research Organization: Loma Linda University, Loma Linda, Calif.

Wien M, Sabate JM, Ikle DN, Cole SE, Kandeel FR. “Almonds vs. Complex Carbohydrates in a Weight Reduction Program.”
International Journal of Plumpness, 2003, vol. 27, pp. 1365-1372. Scrutinization Institution: See of Hope National Medical Center,
Duarte, Calif.

The Almond Board of California welcomes the participation of all persistence members and does not discriminate on the basis
of hare, color, nationwide origin, sexual orientation, gender, marital significance, doctrine, period, impotence or political beliefs.

Almond Ship aboard of California
http://www.AlmondsAreIn.com

Want dazzling insomnia projection without having to cough up lots of cash on overpriced prescriptions and doctor visits? Then you need to follow these 7 insomnia tips. Not on the other hand can they make your sleeping problems less of a problem, but they can also ensure that you’ll gad about get a better nights sleep from minute on!

1. Have a glass of warm milk before bed. Milk is rich in calcium, which aids in relaxing the nerves in your body. If your nerves are relaxed, you’ll become relaxed as a result.

2. Listen to soothing music while in bed. If you have a favorite song that you like to listen to (which is soothing and comforting), play it while trying to fall asleep. If you don’t have any CDs that are soothing, invest in a special CD (or cassette) comprised of gentle sounds, pulses, and rhythmic patterns. Such a CD is designed specifically to help people get to sleep and stay asleep longer. Most individuals report amazing insomnia relief after a few weeks with these “special” CDs.

3. Have a bit of herbal tea before bed. Most herbal tea (such as chamomile or fennel tea) is made up of natural ingredients which help a person to fall asleep faster and to stay asleep longer. Herbal teas can be purchased in a wide variety of places these days, including grocery stores and health food stores.

4. Get a massage to relax you. A nice massage, performed by a loved one, can be great for relaxation purposes. A full body massage would be ideal, but even a quick back-rub or scalp massage will help to provide some measure of insomnia relief.

5. Take a warm bath before going to sleep. Warm baths have strong soothing properties that will help to relax even the most tense individual.

6. Avoid naps during the day. It may seem like a good idea at the time, but a nap can really upset your ability to go to sleep when you’re supposed to. Do your best to stay awake until it is time to go to sleep at night. If you can do that, you’ll find that it’s much easier to fall asleep and stay asleep.

7. Keep a pattern. Make it a goal to go to bed around the same time each night and get up around the same time each morning. Keeping a good sleeping pattern ensures that your body will know exactly when it’s time to sleep and exactly when it’s time to wake up.

Impotencia masculina

If you want amazing insomnia relief, be sure to follow the 7 insomnia tips above. They probably won’t cure your sleeping disorder altogether, but they’re guaranteed to aid in getting you a better nights rest. For more helpful and easy insomnia tips and to find out if you’re suffering from the common sleeping disorder known as insomnia, try visiting http://www.SleepTracks.org, a highly popular website that specializes in the treatment of insomnia and sleeping disorders.

Chicago’s key participant in the RELIANT (Randomized Ranking of the Novacor(r) LVAS In A Non-Transplant Population) research study recently went home from Northwestern Commemorative Hospital.

Percy Pinkdon, a 70-year-old Chicago man, suffered from irreversible end-stage cardiomyopathy, a weakening of the heart muscle that affects its ability to pump blood.

He received unsuccessful cardiac treatments at other hospitals and an existing bone marrow abnormality ruled out a heart transplant. A friend recommended he come to the Bluhm Cardiovascular Institute at Northwestern Memorial Hospital where he learned about a first-of-its-kind, national, multi-center clinical trial that compares heart pumps from two different manufacturers - the Novacor Left Ventricular Assist System (LVAS) and the standard device, the HeartMate VE LVAS - as destination therapy or a permanent treatment for severely ill patients who are not candidates for a heart transplant.

“The field of heart pump technology is evolving. This research trial is important because we need to understand what type of pump will work best in each patient,” said Pinkdon’s surgeon, Edwin McGee, MD, surgical director, Advanced Heart Failure Program at the Bluhm Cardiovascular Institute and assistant professor of surgery at Northwestern University’s Feinberg School of Medicine.

Heart pumps were initially approved as a “bridge-to-transplant,” to assist a person’s ailing heart until a donor heart could be found for transplantation. Three years ago, the Food and Drug Administration (FDA) gave approval for the first time for a heart pump to be used as destination therapy.

Left ventricular assist systems assume the pumping function of the left ventricle of the heart, which pumps blood to the large blood vessel that sends blood to the rest of the body. The systems include an implantable heart pump and mobile external components, connected through a line in the skin that powers the pump. Patients typically carry the power components, which are about the size of a deck of cards, in a holder around the waist. “Destination therapy or permanent placement of ventricular assist systems is in its infancy, but the technology is improving constantly and rapidly,” says John O’Connell, MD, director of the Bluhm Cardiovascular Institute’s Center for Heart Failure. “Soon a proven totally implantable device will be available. While transplantation can be very effective for end stage heart disease, only 2000 are done annually in the United Sates and the number who could benefit from replacement therapy may be as many as 250,000. However, currently destination therapy is available only to those who cannot receive a transplant because of non-cardiac conditions that rule out transplant.”

“The results of a clinical trial in 2001 showed that participants with end-stage heart failure who are not transplant candidates live longer, fuller lives if they receive an LVAS as opposed to being treated with optimal medical therapy,” said Dr. McGee. “These pumps are the best option for those in the worst stages of heart disease who, for whatever reason, are not candidates for a heart transplant.”

“Before getting a heart pump, Mr. Pinkdon was about as sick as you can get,” says Dr. McGee. “The highest doses of medicine were no longer working. His heart was not pumping adequate amounts of blood to his body. We had to implant an intra-aortic balloon pump to reduce the workload of his heart and to improve flow of his blood to the coronary arteries. He required intubation and was placed on a ventilator.”

Mr. Pinkdon had the device implanted in late August and after a nearly two-month recovery at Northwestern Memorial, he says, “I feel great. I’m no longer out of breath or in pain.”

“We are very happy with his progress,” says Dr. McGee. “With either of the pumps we’re studying, participants should have more energy and can basically return to their normal lives.”

impotencia masculina

The Bluhm Cardiovascular Institute, which relaunched its heart transplant program this spring, offers world-class heart services from evaluation to follow-up. “We want to see those patients who have been told nothing else can be done for their heart conditions,” said, Patrick McCarthy, MD, co-director of the Bluhm Cardiovascular Institute of Northwestern Memorial Hospital and chief, Cardiothoracic Surgery, Northwestern Memorial. “We’ve performed surgery on many patients who’ve been told they aren’t surgical candidates and have done beautifully with complex bypasses or valve repairs. However, when repairs are not possible, we have a team with the experience and knowledge to evaluate patients and offer transplant if at all possible. If not, we can offer the latest generation of heart pumps, and it is hoped that participants will do well with these.”

“Cooperation of the primary care physician, cardiologist and heart surgeon is critical to an optimal result,,” says O’Connell, who was one of Mr. Pinkdon’s cardiologists. “We have assembled a team of nurses, cardiologists and surgeons that work together to personalize the approach to the management of care with the goal of achieving the best outcome possible for each of our patients.”

http://www.nmh.org/

$90 million for a top-notch nanotech lab

The two partners possess a protracted-standing tradition of scientific cooperation, and now make an high-level step to concentrate this collaboration further by forming a strategic partnership in the field of nanotechnology. The collaborative project was revealed at a joint media discussion in Zurich by Prof. Ralph Eichler, President of ETH Zurich, and John E. Kelly III, Senior Corruption-President and Director of IBM Experiment with. As part of this collaboration, a new edifice with cutting-edge research facilities last will and testament be constructed on the campus of the IBM Zurich Research Laboratory in Rüschlikon (CH), with the laying of the foundation stone scheduled in origin 2009, and the start of research activities in 2011.

A value-add proper for Swiss business

“This nanotech lab will have a strong value-sum up, not solitary for the participating institu-tions, but for the treatment of Swiss industry as a whole,” said Professor Ralph Eichler, “as we are open to collaborations with Swiss companies and analysis institutes.” With EMPA - the Swiss interdisciplinary investigating organization for material sciences and technology devel-opment - one additional fellow for collaboration is already involved. The collaboration brings with it considerable potential repayment for the creation of novel production techniques from which Switzerland, with its sizeable community of SMEs, resolve profit.

The nanotech lab will make world-beating research tenable, but the partnership itself is also innovative. «By creating this common research center, IBM is expanding a collabo-rative and cooperative exploration program aimed at accelerating our understanding and implementation of nanotechnology and its rude roam of applications”, said Dr. Kelly. “We see this type of collaboration as an emerging scale model for future industry-theoretical partnerships.”

New edifice - shared infrastructure

The two institutions will spotlight on analysis in various fields of nanotechnology, ranging from exploratory and basic research to applied and near-term projects. Some areas for union probing projects press been identified, such as carbon-based materials, nano-photonics, spintronics, nanowires, and tribology. The novel concept of a shared re-search facility with more than 900 m2 of cleanroom area will be built in the nanotech lab with three sections: one each after clannish profit by by IBM and ETH Zurich, as well as an room that both partners wish part. The costs of the new construction amount to 90 million USD, of which 30 million USD alone will be dedicated to cutting-lip infrastructure. The partners will allowance expenditure looking for infrastructure; the erection investment itself last will and testament be undertaken by IBM. ETH Zurich will rent the period and share the operations costs with IBM. The strategic partnership is intended to be in place for at least 10 years. Apart from roast research activities each partner sanitarium is free to pursue its own projects.

For ETH Zurich the imaginative Nanotech Lab on the IBM campus at Rüschlikon is a perfect complement to the existing check in infrastructure at ETH Zurich Hönggerberg and big apple-located sites. An well-connected point of view of the new center is the unrivalled opportunity in the service of ETH Zurich students to quest after their study in close collaboration with an industrial partner, which is an important asset in ETH Zurich’s engineering edification.

Cue technology of the 21st century

Today numerous products based on nanotechnology are on the exchange already, and scads more are being developed. Nanotechnology defines a technology that utilizes functions at an extraordinarily small-size gradation. It focuses on structures and processes in dimensions below 100 nanometers - roughly 400 times thinner than a human fraction. At the scale of nanometers, many fundamental processes of biology, chemistry and physics be brought to someone’s attention and can be controlled in unprecedented ways, offering astonishing new perspectives in assorted disciplines.

Impotencia

Nanotechnology is an enabling technology which is expected to speck advances in heterogeneous fields. These involve advanced functional materials, nanoelectronics, information and communication technology, sensing, tools, healthcare and spring sciences, and pep technology. In particular, nanotech applications in the energy sector, such as more efficient use of solar energy, or revitalized ways of water treatment, might even relief to tackle some of the biggest challenges of our nevertheless.

With its into at ETH Zurich and the IBM Zurich Probing Lab, Zurich is one of the hotspots of quantum mechanics and nano research. And this is so for an barring rea-son: ground breaking concepts in quantum mechanics have been formulated by ETH physicist and Nobel Laureate, Wolfgang Pauli. Gerhard Binning and Heinrich Rohrer received the Nobel First-rate in Physics in 1986 representing the development of the scanning tunneling microscope at the IBM Zurich Research Lab. This thingy allowed the first look into the area of atoms, that reason throwing the door to nanotechnology research wide open. A lot of potential nevertheless still remains to be unlocked. With the reborn lab, ETH Zurich and ZRL are exact to carry out nanotechnology to the next level.

—————————-
Article adapted by Medical News Today from original press liberating.
—————————-

Source: Roman Klingler

ETH Zurich/Swiss Federal Institute of Technology